Invasive aspergillosis associated with COVID-19
https://doi.org/10.18093/0869-0189-2021-31-5-671-676
Abstract
The novel coronavirus (COVID-19) pandemic announced by the World Health Organization in March 2020 has brought new tasks to the medical community that require immediate solutions. Recent studies have shown that invasive aspergillosis associated with coronavirus infection caused by COVID-19 often aggravates the course of the disease and leads to death. The article presents a clinical case of acute invasive aspergillosis in a COVID-19 patient with chronic somatic pathology but no risk factors for developing invasive pulmonary aspergillosis. The disease was progressing rapidly and led to a fatal outcome.
Conclusion. In the case presented, invasive pulmonary aspergillosis was diagnosed with the help of histological examination of autopsy material.
About the Authors
Nikolay V. Ovsyannikov
Omsk State Medical University, Healthcare Ministry
Russian Federation
Competing Interests:
Russian Federation
Nikolay V. Ovsyannikov, Doctor of Medicine, Head of Department of Internal Diseases Propedeutics
ul. Leninа 12, Omsk, 644099
tel.: (3812) 73-33-37
Competing Interests:
The authors declare no conflict of interest
Olga A. Bilevich
Omsk State Medical University, Healthcare Ministry
Russian Federation
Competing Interests:
Russian Federation
Olga A. Bilevich, Candidate of Medicine, Associate Professor, Department of Internal Diseases Propedeutics
ul. Leninа 12, Omsk, 644099
tel.: (3812) 73-33-37
Competing Interests:
The authors declare no conflict of interest
Lyudmila A. Zenkova
Omsk State City Teaching Hospital No.11
Russian Federation
Competing Interests:
Russian Federation
Lyudmila A. Zenkova, Head of Department for the treatment of COVID-19
ul. Nakhimova 55, Omsk, 644105
tel.: (3812) 28-42-88
Competing Interests:
The authors declare no conflict of interest
Olga V. Vasilieva
Omsk State Medical University, Healthcare Ministry; Omsk State City Teaching Hospital No.11
Russian Federation
Competing Interests:
Russian Federation
Olga V. Vasilyeva, Candidate of Medicine, Assistant Lecturer, Department of Human Anatomy
ul. Leninа 12, Omsk, 644099;
ul. Nakhimova 55, Omsk, 644105
tel.: (3812) 61-82-29
Competing Interests:
The authors declare no conflict of interest
References
1. Lu R., Zhao X., Li J. et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395 (10224): 565–574. DOI: 10.1016/s0140-6736(20)30251-8.
2. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int [Accessed: March 03, 2021].
3. Ministry of Health of the Russian Federation [The prevention, diagnosis and treatment of the new coronavirus infection (COVID-19): Temporary guidelines]. Version 10 (08.02.2021). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/588/original/Временные_МР_COVID-19_%28v.10%29-08.02.2021_%281%29. pdf [Accessed: March 13, 2021] (in Russian).
4. Chuchalin A.G., ed. [Pulmonology: national guide. Short edition]. Moscow: GEOTAR-Media; 2020 (in Russian).
5. Yaqinuddin A., Kashir J. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents. Med. Hypotheses. 2020; 140: 109777. DOI: 10.1016/j.mehy.2020.109777.
6. Kostinov M.P., Markelova E.V., Svitich O.A., Polishchuk V.B. [Immune mechanisms of SARS-CoV-2 and potential drugs in the prevention and treatment of COVID-19]. Pul’monologiya. 2020; 30 (5): 700–708. DOI: 10.18093/0869-0189-2020-30-5-700-708 (in Russian).
7. Marr K.A., Platt A., Tornheim J.A. et al. Aspergillosis complicating severe coronavirus disease. Emerg. Infect. Dis. 2021; 27 (1): 18–25. DOI: 10.3201/eid2701.202896.
8. Lai C.C., Yu W.L. COVID-19 associated with pulmonary aspergillosis: A literature review. J. Microbiol. Immunol. Infect. 2021; 54 (1): 46–53. DOI: 10.1016/j.jmii.2020.09.004.
9. Borman A.M., Palmer M.D., Fraser M. et al. COVID-19-associated invasive aspergillosis: data from the UK national mycology reference laboratory. J. Clin. Microbiol. 2020; 59 (1): e02136–20. DOI: 10.1128/JCM.02136-20.
10. Koehler P., Bassetti M., Chakrabarti A. et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ ISHAM consensus criteria for research and clinical guidance. Lancet Infect. Dis. 2021; 21 (6). e149–162. DOI: 10.1016/S1473-3099(20)30847-1.
Review
For citations:
Ovsyannikov N.V., Bilevich O.A., Zenkova L.A., Vasilieva O.V. Invasive aspergillosis associated with COVID-19. PULMONOLOGIYA. 2021;31(5):671-676. (In Russ.) https://doi.org/10.18093/0869-0189-2021-31-5-671-676
Views:
10044
Email this article 